Open Access<p>The <em>AKR1D1*36</em> (<em>rs1872930</em>) Allelic Variant Is Independently Associated With Clopidogrel Treatment Outcome</p>
Author(s) -
Aleksandra Kapedanovska-Nestorovska,
Aleksandar Dimovski,
Zoran Sterjev,
Nadica Matevska Geskovska,
Ljubica Šuturkova,
Petar Ugurov,
Zan Mitrev,
Rodney Alexander Rosalia
Publication year - 2019
Publication title -
pharmacogenomics and personalized medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.845
H-Index - 28
ISSN - 1178-7066
DOI - 10.2147/pgpm.s222212
Subject(s) - medicine , hazard ratio , clopidogrel , proportional hazards model , myocardial infarction , cohort , gastroenterology , percutaneous coronary intervention , conventional pci , cardiology , confidence interval
The present observational cohort study evaluated the association between the AKR1D1*36 (rs1872930) allele and the risk of major adverse cardiovascular and cerebrovascular events (MACCE) in clopidogrel treated patients.